Baker’s yeast has been well-known to have the ability to reduce a variety of substrates into many optically active compounds. One of the important chemicals is (4R,6R)-4-hydroxy-2,2,6-trimethylcyclohexanone or in short, (4R,6R)-actinol, a product formed from the reduction of 2,6,6-trimethylcyclohex-2-ene-1,4-dione, (ketoisophorone). The work has successfully characterized the route of the reaction during the conversion mediated by Saccharomyces cerevisiae and it was also experimentally observed the importance of cofactor (NADH/NADPH) availability and stability during the biotransformation. The presence of cofactor has been proven to assist the product formation by keeping a continuous flow of hydrogen ions to and from the reduction system, while the amount of enzymes present determined the rate of both intermediates and product formed during the course of biotransformation. Results of the growing cells, particularly during the exponential phase of the growth significantly differ to that of the stationary phase system in terms of the formation of the intermediates and the final product. For the growing cell biotransformation, the route only stopped at the intermediate compound (4) during the course of the 30 h reaction, whereas for the stationary phase biotransformation, compound (5) was readily formed in a range of time between 2 and 12 h of reaction, depending on the amount of cells available and glucose supplied to the system. Within the yeast cell, there are two responsible enzymes that mediate the biotransformation; carbonyl reductase and enoate reductase that work both in parallel and sequential to produce a chiral alcohol of (4R,6R)-actinol.